Eli Lilly director granted 13.45 shares at $1,183
ELI LILLY & Co (LLY) director Juan R. Luciano reported the acquisition of 13.4527 shares of common stock on 2026-08-17 through a grant/award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ELI LILLY & Co (LLY) director Juan R. Luciano reported the acquisition of 13.4527 shares of common stock on 2026-08-17 through a grant/award. According to the deferral election, these shares have been credited as stock units under the Lilly Directors' Deferral Plan in lieu of cash compensation and will be settled in common stock after his separation from service. Following this award, his directly owned position is reported as 16,918.0448 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 13.4527 | $1,183.16 | $16K |
Footnotes (1)
- F1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Key Figures
Key Terms
Lilly Directors' Deferral Plan financial
stock units financial
deferred in lieu of cash compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did LLY director Juan R. Luciano report on this Form 4?
What was the price used for the LLY stock grant to Juan R. Luciano?
How was the LLY director’s compensation structured in this Form 4 transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.